Prophylaxis Vaccine Antibodies Ebola

Clinical trial NCT04822376 · UNKNOWN

Trial details

NCT number: NCT04822376
Sponsor: ANRS, Emerging Infectious Diseases
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Ebola Virus Disease

Start date: 2021-10-17
Primary completion: 2022-04-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.